Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Medical Device is an Alternative to Open-Heart Surgery

By R&D Editors | August 25, 2014

Professor Noel Caplice, UCC with the medical device Image ProvisionUniversity College Cork’s Centre for Research in Vascular Biology has developed a new device that promotes the bypass of arterial obstructions, potentially removing the need for major surgery.

Worldwide, there are approximately three million open heart coronary bypass and peripheral artery bypass operations each year. These procedures involve major surgery with inherent risks of anesthesia, ventilation, surgical trauma and potential complications such as kidney failure and wound infection.  Around 20% of all patients requiring surgery are unable to undergo such bypass procedures because of the poor status of their arteries or co-existing illness that would make the risk of surgery too great.

Publishing in Biomaterials, the research project (led by Professor Noel Caplice in UCC with collaborators in the Mayo Clinic) has developed a vascular cell delivery device and tested it successfully in a large animal model with similar sized arteries to humans. The device is inserted via a keyhole procedure through the artery to the site of obstruction and promotes micro-bypass of this obstruction over a four week period. This results in the return of normal heart function and a recovery of full exercise capacity.

Professor Noel Caplice, Director of the Centre for Research in Vascular Biology at UCC and Chair of Cardiovascular Sciences, says, “If reproduced in humans this device would offer an alternative to open surgical bypass operations with implications for treatment of patients who are currently inoperable. It also has the potential to reduce costs and time spent in hospital.” Professor Caplice is a practicing interventional cardiologist.

Plans are now in place to test this technology over the coming years in patients who require bypass surgery but would otherwise be deemed unfit for surgical intervention.

“We anticipate that this work could be completed over the next 3-5 years,” says Professor Caplice.

This work originated from a question of how you could help a person to grow their own blood vessels without major surgery. While working at the Mayo Clinic Professor Caplice and colleagues designed a mesh device that could be attached to a stent which could deliver millions of cells which would promote bypass in an obstructed artery. Since returning to UCC in 2005 Professor Caplice has developed this technology so that it can be delivered using a catheter. He has proven the principle of his microbypass device on animals and the device is now ready to be tested in human subjects. 

When the prototype of this device was first envisaged Professor Caplice worked with a bioengineering colleague in the USA who used a soldering iron and heatsink to put together the cell carrier component in a workshop at the back of his garage. Over time this technique was refined until a hybrid device carrying millions of cells could be safely delivered in an artery within the body. They discovered that the structure of the device’s fiber network and its coating were key to the efficient and long lasting placement of therapeutic cells in the device. This initial optimization took more than five years’ work.

The research was funded by grants initially from the National Institutes of Health (NIH-NHLBI) in the USA and more recently by Science Foundation Ireland.

The Centre for Research in Vascular Biology at UCC addresses fundamental questions in relation to cardiovascular disease. The Centre focuses on new therapies for heart repair and on discovering new technologies to treat severe vascular disease which is currently inoperable. 

Release Date: August 25, 2014
Source: University College Cork 

Related Articles Read More >

Probiotics power a bioresorbable battery that can run from 4 to 100+ minutes
2025 R&D layoffs tracker tops 92,000
Health-related innovation in Morocco highlighted by resident inventor patenting activity
ARPA-H funds $29M Ginkgo-led project to reshore pharma supply chains using wheat germ tech
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE